{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:00:43Z","timestamp":1792112443334,"version":"4.4.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01584","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T03:51:31Z","timestamp":1580442691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17\/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-\/- Mice Model of Early and Mid-Term Atherosclerosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Qinghong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihe","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Verkhratsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.medici.2014.11.009","article-title":"Atherogenic index as a predictor of atherosclerosis in subjects with familial Mediterranean fever","volume":"50","author":"Acay","year":"2014","journal-title":"Med. (Kaunas)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/atvbaha.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis","volume":"31","author":"Ait-Oufella","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/MOL.0b013e328357a379","article-title":"Macrophage proliferation and apoptosis in atherosclerosis","volume":"23","author":"Andr\u00e9s","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"TH-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1161\/circ.99.16.2079","article-title":"Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circ. (New York N.Y.)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9747212","article-title":"Protective effects of Angong Niuhuang Pill on early atherosclerosis in ApoE(-\/-) mice by reducing the inflammatory response","author":"Chai","year":"2019","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1074-7613(00)00041-8","article-title":"Signaling by the TNF receptor superfamily and T cell homeostasis","volume":"13","author":"Chan","year":"2000","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3969\/j.issn.1000-3614.2018.01.001","article-title":"China cardiovascular disease report 2017 summary","volume":"33","author":"Chen","year":"2018","journal-title":"Chin. Circ. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yexmp.2018.01.008","article-title":"Potential of anti-inflammatory agents for treatment of atherosclerosis","volume":"104","author":"Chistiakov","year":"2018","journal-title":"Exp. Mol. Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation"},{"key":"B12","volume-title":"The Pharmacopoeia of Peoples Republic of China 2015","year":"2015"},{"key":"B13","doi-asserted-by":"publisher","first-page":"549137","DOI":"10.1155\/2011\/549137","article-title":"LDL-C\/HDL-C ratio predicts carotid intima-media thickness progression better than HDL-C or LDL-C alone","volume":"2011","author":"Enomoto","year":"2011","journal-title":"J. Lipids"},{"key":"B14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000441085","article-title":"Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study","volume":"45","author":"Feigin","year":"2015","journal-title":"Neuroepidemiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jep.2016.11.015","article-title":"Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis","volume":"195","author":"Fu","year":"2017","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-\u03b3 potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B18","first-page":"38","article-title":"Effect of Angong Niuhuang Pill on liver of experimental brain edema animals","volume":"12","author":"He","year":"1992","journal-title":"Jiangsu J. Trad. Chin. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1161\/01.ATV.0000143384.69170.2d","article-title":"Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice","volume":"24","author":"Ishibashi","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1615\/CritRevImmunol.2014010802","article-title":"T\u00a0regulatory cells: a promising new target in atherosclerosis","volume":"34","author":"Konstantinos","year":"2014","journal-title":"Crit. Rev. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/CIRCULATIONAHA.107.708016","article-title":"Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice","volume":"116","author":"Krohn","year":"2007","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1189\/jlb.72.3.503","article-title":"Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1\u03b2 or tumor necrosis factor","volume":"72","author":"Lisinski","year":"2002","journal-title":"J.\u00a0Leukocyte Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/1753-0407.12132","article-title":"ERK5: novel mediator of insulin and TNF-stimulated VCAM-1 expression in vascular cells","volume":"6","author":"Mackesy","year":"2014","journal-title":"J. Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/01.ATV.0000128849.12617.f4","article-title":"Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress","volume":"24","author":"Meir","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.atv.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"B27","volume-title":"Public Health Service policy on human care and use of laboratory animals","year":"2015"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1096\/fj.06-6084fje","article-title":"IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression","volume":"20","author":"Rajasingh","year":"2006","journal-title":"FASEB J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","article-title":"Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets","volume":"26","author":"Ramji","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/nejm199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"New Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Shimon","year":"2006","journal-title":"Immunol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0623-6","article-title":"Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17\/Treg balance in AMPK-dependent mechanisms","volume":"16","author":"Tian","year":"2017","journal-title":"Cardiovasc. Diabetol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur. Heart J."},{"key":"B35","first-page":"1923","article-title":"The effects of T helper 17 and regulatory T cells on patients with carotid atherosclerosis","volume":"30","author":"Wang","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jtbi.2018.08.010","article-title":"A two-phase model of early fibrous cap formation in atherosclerosis","volume":"456","author":"Watson","year":"2018","journal-title":"J. Theor. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18102034","article-title":"New insights into the role of inflammation in the pathogenesis of atherosclerosis","volume":"18","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cyto.2009.09.007","article-title":"The Th17\/Treg functional imbalance during atherogenesis in ApoE(-\/-) mice","volume":"49","author":"Xie","year":"2010","journal-title":"Cytokine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1189\/jlb.1009671","article-title":"Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases","volume":"88","author":"Zhao","year":"2010","journal-title":"J. Leukoc. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01584\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T03:51:35Z","timestamp":1580442695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01584\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":40,"alternative-id":["10.3389\/fphar.2019.01584"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01584","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"article-number":"1584"}}